NovoSeven® RT with MixPro™

NovoSeven® RT Coagulation Factor VIIa (Recombinant) Room Temperature Stable is indicated for:

- Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX and in patients with acquired hemophilia
- Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX and in patients with acquired hemophilia
- Treatment of bleeding episodes in patients with congenital FVII deficiency
- Prevention of bleeding in surgical interventions or invasive procedures in patients with congenital FVII deficiency

NovoSeven® RT is also provided with a sterile vial adapter and a pre-filled diluent syringe (named NovoSeven® RT with MixPro), which together serve as an alternative needleless reconstitution system. NovoSeven® RT package containing 1 vial of NovoSeven® RT powder and 1 pre-filled histidine diluent syringe with vial adapter.

For indications, dosing and other information, please refer to the prescribing information.

NovoSeven® RT ‐ NovoNordisk

Size:
1000 mcg, 1 mL Syringe with MixPro®
NDC #:
00169-7201-01
Download:
PI
Size:
2000 mcg, 2 mL Syringe with MixPro®
NDC #:
00169-7202-01
Download:
PI
Size:
5000 mcg, 5 mL Syringe with MixPro®
NDC #:
00169-7205-01
Download:
PI
Size:
8000 mcg, 8 mL Syringe with MixPro®
NDC #:
00169-7208-01
Download:
PI